Transmedics Group Inc (TMDX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt TMDX? Forum Prognose

Finanzdaten der Transmedics Group Inc-Aktie (TMDX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-09-30	2024-06-30	2024-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	9.64% 157.37	143.54	108.76	114.31	96.85
Cost Of Revenue	9.89% 60.78	55.31	47.92	45.04	36.89
Gross Profit	9.48% 96.59	88.23	60.84	69.26	59.96
Operating Expenses	1.26% 60.02	60.78	56.92	56.75	47.54
Benefits Costs and Expenses	3.70% 121.19	116.86	104.52	102.15	84.46
Costs And Expenses	3.70% 121.19	116.86	104.52	102.15	84.46
Operating Income/Loss	33.25% 36.57	27.44	3.923	12.51	12.42
Nonoperating Income/Loss	49.80% -0.385	-0.767	0.322	-0.355	-0.028
Income/Loss From Continuing Operations Before Tax	35.64% 36.18	26.68	4.245	12.15	12.39
Income Tax Expense/Benefit	28.27% 1.275	0.994	0.029	-0.041	0.196
Income/Loss From Continuing Operations After Tax	35.92% 34.91	25.68	4.216	12.19	12.20
Net Income/Loss	35.92% 34.91	25.68	4.216	12.19	12.20
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.57% 33.91	33.72	33.44	33.12	32.76
Diluted Average Shares	1.61% 40.56	39.91	35.68	35.29	34.68
Basic Earnings Per Share	35.53% 1.03	0.76	0.13	0.37	0.37
Diluted Earnings Per Share	31.43% 0.92	0.70	0.12	0.35	0.35
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

STE

$245.30

0.78%

PODD

$348.43

0.57%

PHG

$27.93

0.72%

DXCM

$80.51

0.31%

GEHC

$75.73

2.17%

$80.94

0.02%